12 research outputs found
Clinical outcomes and kinetics of propanil following acute self-poisoning: a prospective case series
A framework for integrated environmental health impact assessment of systemic risks
Traditional methods of risk assessment have provided good service in support of policy, mainly in relation to standard setting and regulation of hazardous chemicals or practices. In recent years, however, it has become apparent that many of the risks facing society are systemic in nature – complex risks, set within wider social, economic and environmental contexts. Reflecting this, policy-making too has become more wide-ranging in scope, more collaborative and more precautionary in approach. In order to inform such policies, more integrated methods of assessment are needed. Based on work undertaken in two large EU-funded projects (INTARESE and HEIMTSA), this paper reviews the range of approaches to assessment now in used, proposes a framework for integrated environmental health impact assessment (both as a basis for bringing together and choosing between different methods of assessment, and extending these to more complex problems), and discusses some of the challenges involved in conducting integrated assessments to support policy
Appropriate use criteria for amyloid PET imaging cannot replace guidelines: On behalf of the European Association of Nuclear Medicine
DNA Damage, Homology-Directed Repair, and DNA Methylation
To explore the link between DNA damage and gene silencing, we induced a DNA double-strand break in the genome of Hela or mouse embryonic stem (ES) cells using I-SceI restriction endonuclease. The I-SceI site lies within one copy of two inactivated tandem repeated green fluorescent protein (GFP) genes (DR-GFP). A total of 2%–4% of the cells generated a functional GFP by homology-directed repair (HR) and gene onversion. However, ;50% of these recombinants expressed GFP poorly. Silencing was rapid and associated with HR and DNA methylation of the recombinant gene, since it was prevented in Hela cells by 5-aza-29-deoxycytidine. ES cells deficient in DNA methyl transferase 1 yielded as many recombinants as wild-type cells, but most of these recombinants expressed GFP robustly. Half of the HR DNA molecules were de novo methylated, principally downstream to the double-strand break, and half were undermethylated relative to the uncut DNA. Methylation of the repaired gene was independent of the methylation status of the converting template. The methylation pattern of recombinant molecules derived from pools of cells carrying DR-GFP at different loci, or from an individual clone carrying DR-GFP at a single locus, was comparable. ClustalW analysis of the sequenced GFP molecules in Hela and ES cells distinguished recombinant and nonrecombinant
DNA solely on the basis of their methylation profile and indicated that HR superimposed novel methylation profiles on top of the old patterns. Chromatin immunoprecipitation and RNA analysis revealed that DNA methyl transferase 1 was bound specifically to HR GFP DNA and that methylation of the repaired segment contributed to the silencing of GFP expression. Taken together, our data support a mechanistic link between HR and DNA methylation and suggest that DNA methylation in eukaryotes marks homologous recombined segments
Stimulatory autoantibodies against PDGF receptor in systemic sclerosis
Background
Systemic sclerosis (scleroderma) is characterized by immunologic abnormalities,
injury of endothelial cells, and tissue fibrosis. Abnormal oxidative stress has been
documented in scleroderma and linked to fibroblast activation. Since platelet-derived
growth factor (PDGF) stimulates the production of reactive oxygen species (ROS)
and since IgG from patients with scleroderma reacts with human fibroblasts, we
tested the hypothesis that patients with scleroderma have serum autoantibodies
that stimulate the PDGF receptor (PDGFR), activating collagen-gene expression.
Methods
We analyzed serum from 46 patients with scleroderma and 75 controls, including
patients with other autoimmune diseases, for stimulatory autoantibodies to PDGFR
by measuring the production of ROS produced by the incubation of purified IgG
with mouse-embryo fibroblasts carrying inactive copies of PDGFR α or β chains or
the same cells expressing PDGFR α or β. Generation of ROS was assayed with and
without specific PDGFR inhibitors. Antibodies were characterized by immunoprecipitation,
immunoblotting, and absorption experiments.
Results
Stimulatory antibodies to the PDGFR were found in all the patients with scleroderma.
The antibodies recognized native PDGFR, inducing tyrosine phosphorylation
and ROS accumulation. Autoantibody activity was abolished by preincubation
with cells expressing the PDGFR α chain or with recombinant PDGFR or by PDGFR
tyrosine kinase inhibitors. Stimulatory PDGFR antibodies selectively induced the
Ha-Ras-ERK1/2 and ROS cascades and stimulated type I collagen–gene expression
and myofibroblast phenotype conversion in normal human primary fibroblasts.
Conclusions
Stimulatory autoantibodies against PDGFR appear to be a specific hallmark of
scleroderma. Their biologic activity on fibroblasts strongly suggests that they have
a causal role in the pathogenesis of the disease